{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:13:32Z","timestamp":1788880412772,"version":"build-2803163510"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"\n Importance<\/jats:title>\n Effective, safe, and infant-friendly interventions are needed to prevent transitional neonatal hypoglycemia, neonatal unit admissions, and neurological sequelae.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine if prophylactic buccal dextrose gel at 1 hour of age in at-risk late preterm and term infants improves neurocognitive function at 6 to 7 years of age, without adverse effects on general health and well-being.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This study focused on school-age follow-up of children in the Hypoglycaemia Prevention With Oral Dextrose (hPOD) multicenter, double-blind, 2-arm, parallel, placebo-controlled trial. Participants were recruited at birth across 9 hospitals in New Zealand. Follow-up was conducted primarily at the children\u2019s schools. Children in the hPOD Trial were born at 35 weeks\u2019 or more gestation and weighed 2.2 kg or more with 1 or more risk factors for transitional neonatal hypoglycemia: preterm, maternal diabetes, small or large for gestational age, or birth weight less than 2.5 kg or more than 4.5 kg. The assessments for this study (data collection) were performed from April 2021 to July 2025. The primary database extraction was on July 24, 2025. Data analysis was completed in October 2025.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n A 0.2-g\/kg dose of buccal or placebo (hydroxymethylcellulose, 2%) at 1 hour of age.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measures<\/jats:title>\n The primary outcome for this follow-up study was neurocognitive impairment at 6 to 7 years of age, defined as a standard score more than 1 SD below the normative mean on 1 or more of 7 items from the National Institutes of Health Toolbox. Eleven main exploratory outcomes included components of the primary outcome, low numeracy, visual perception, emotional-behavioral difficulty (Strengths and Difficulties Questionnaire), low physical or psychosocial functioning (Child Health Questionnaire), and overweight\/obesity.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n There were 532 of 652 (252 female and 280 male [82%]) eligible children assessed in the dextrose gel group and 535 of 642 (271 female and 264 male [83%]) in the placebo group. The proportion with neurocognitive impairment was similar between groups (dextrose gel, 59%, vs placebo, 57%; adjusted risk difference [aRD], 3%; 95% CI, \u22123% to 9%;\n P<\/jats:italic>\n \u2009=\u2009.36). Of exploratory outcomes, children who received dextrose gel, compared with placebo, were more likely to have emotional-behavioral difficulty (24% vs 18%; aRD, 7%; 95% CI, 1%-12%) and low psychosocial function (17% vs 12%; aRD, 6%; 95% CI, 1%-10%). Other outcomes were similar between groups.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this follow-up study, a single dose of dextrose gel to prevent hypoglycemia, compared with placebo, had little to no effect on the risk of neurocognitive impairment at early school age, but could have adverse effects on psychological well-being. The current evidence does not support the routine use of dextrose gel for the prevention of neonatal transitional hypoglycemia.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n Australian New Zealand Clinical Trials Registry Identifier:\n ACTRN12614001263684<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2026.2486","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:30:38Z","timestamp":1782747038000},"page":"934","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic Dextrose Gel for Neonatal Hypoglycemia and Neurocognitive Function at 6 to 7 Years of Age"],"prefix":"10.1001","volume":"180","author":[{"given":"Jane E.","family":"Harding","sequence":"first","affiliation":[{"name":"Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Alsweiler","sequence":"additional","affiliation":[{"name":"Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand"},{"name":"Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin T. L.","family":"Brown","sequence":"additional","affiliation":[{"name":"Arts and Education, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Gamble","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"McNeill","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Rogers","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thompson","sequence":"additional","affiliation":[{"name":"School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada"},{"name":"School of Optometry and Vision Science, University of Auckland, Auckland, New Zealand"},{"name":"Centre for Eye and Vision Research, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Turuwhenua","sequence":"additional","affiliation":[{"name":"Auckland Bioengineering Institute, University of Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trecia A.","family":"Wouldes","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, University of Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. D.","family":"McKinlay","sequence":"additional","affiliation":[{"name":"Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"hPOD Study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coila J","family":"Bevan","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliia","family":"Burakevych","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Dai","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ivashkova","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mikaelian","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Park","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Shah","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Wei","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A","family":"Samuel","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Meagher Lundberg","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Edlin","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Crowther","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E","family":"Hegarty","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nyakotey","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Geoffrey","family":"Chase","sequence":"additional","affiliation":[{"name":"for the hPOD Study group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"poi260035r1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamapediatrics.2023.3957","article-title":"Infants eligible for neonatal hypoglycemia screening: a systematic review.","volume":"177","author":"O\u2019Brien","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"5","key":"poi260035r2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jpeds.2012.05.022","article-title":"Incidence of neonatal hypoglycemia in babies identified as at risk.","volume":"161","author":"Harris","year":"2012","journal-title":"J Pediatr"},{"issue":"10","key":"poi260035r3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years.","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"key":"poi260035r4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jpeds.2018.02.036","article-title":"Cost-analysis of treating neonatal hypoglycemia with dextrose gel.","volume":"198","author":"Glasgow","year":"2018","journal-title":"J Pediatr"},{"issue":"6","key":"poi260035r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.15764","article-title":"Diazoxide for severe or recurrent neonatal hypoglycaemia: a randomized clinical trial.","volume":"7","author":"Laing","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"8","key":"poi260035r6","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1542\/hpeds.2025-008375","article-title":"Burden of \u201cpokes\u201d in newborns with hypoglycemia who require IV dextrose.","volume":"15","author":"Frymoyer","year":"2025","journal-title":"Hosp Pediatr"},{"issue":"3","key":"poi260035r7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011027.pub3","article-title":"Oral dextrose gel for the treatment of hypoglycaemia in newborn infants.","volume":"3","author":"Edwards","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"poi260035r8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012152.pub4","article-title":"Oral dextrose gel to prevent hypoglycaemia in at-risk neonates.","volume":"11","author":"Roberts","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"poi260035r9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002155","article-title":"Prophylactic oral dextrose gel for newborn babies at risk of neonatal hypoglycaemia: a randomised controlled dose-finding trial (the Pre-hPOD Study).","volume":"13","author":"Hegarty","year":"2016","journal-title":"PLoS Med"},{"issue":"3","key":"poi260035r10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/archdischild-2020-320305","article-title":"Two-year outcomes after dextrose gel prophylaxis for neonatal hypoglycaemia.","volume":"106","author":"Griffith","year":"2021","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"poi260035r11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/archdischild-2023-326452","article-title":"Dextrose gel prophylaxis for neonatal hypoglycaemia and neurocognitive function at early school age: a randomised dosage trial.","volume":"109","author":"Wei","year":"2024","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"poi260035r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2023-000544","article-title":"Neonatal hypoglycaemia.","volume":"3","author":"Harding","year":"2024","journal-title":"BMJ Med"},{"issue":"1","key":"poi260035r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003411","article-title":"Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): A multicenter, double-blind randomized controlled trial.","volume":"18","author":"Harding","year":"2021","journal-title":"PLoS Med"},{"key":"poi260035r14","doi-asserted-by":"publisher","DOI":"10.32641\/andespediatr.v94i1.4220","article-title":"Neonatal hypoglycemia: glucose gel efficacy in the treatment of early hypoglycemia in newborns with risk factors. Randomized clinical trial.","author":"Del Carmen Covas","year":"2023","journal-title":"Andes Pediatrica"},{"issue":"12","key":"poi260035r15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/jama.2022.2363","article-title":"Prophylactic oral dextrose gel and neurosensory impairment at 2-year follow-up of participants in the hPOD randomized trial.","volume":"327","author":"Edwards","year":"2022","journal-title":"JAMA"},{"key":"poi260035r17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081123","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials.","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"poi260035r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.114119","article-title":"Neonatal hypoglycemia and neurocognitive function at school age: a prospective cohort study.","volume":"272","author":"Wei","year":"2024","journal-title":"J Pediatr"},{"key":"poi260035r19","doi-asserted-by":"publisher","DOI":"10.1080\/09297049.2024.2447444","article-title":"NIH Toolbox for assessment of neurocognitive, motor and emotional-behavioral function in childhood: a systematic review.","author":"Wei","year":"2025","journal-title":"Child Neuropsychology"},{"key":"poi260035r20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.visres.2017.04.005","article-title":"Global motion perception is related to motor function in 4.5-year-old children born at risk of abnormal development.","volume":"135","author":"Chakraborty","year":"2017","journal-title":"Vision Res"},{"issue":"1","key":"poi260035r21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40841-015-0001-4","article-title":"An analysis of an assessment tool for 5-year old students entering elementary school: the School Entry Assessment Kit.","volume":"50","author":"Hattie","year":"2015","journal-title":"N Z J Educ Stud"},{"issue":"9","key":"poi260035r22","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents.","volume":"85","author":"de Onis","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"3","key":"poi260035r23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3945\/ajcn.2009.28385","article-title":"Reference curves for triceps and subscapular skinfold thicknesses in US children and adolescents.","volume":"91","author":"Addo","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"poi260035r24","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1519\/JSC.0000000000001678","article-title":"Reference curves for field tests of musculoskeletal fitness in U.S. children and adolescents: the 2012 NHANES National Youth Fitness Survey.","volume":"31","author":"Laurson","year":"2017","journal-title":"J Strength Cond Res"},{"issue":"5","key":"poi260035r25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1469-7610.1997.tb01545.x","article-title":"The Strengths and Difficulties Questionnaire: a research note.","volume":"38","author":"Goodman","year":"1997","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"poi260035r26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/jech.2003.012914","article-title":"Reliability and validity of the short form of the child health questionnaire for parents (CHQ-PF28) in large random school based and general population samples.","volume":"59","author":"Raat","year":"2005","journal-title":"J Epidemiol Community Health"},{"issue":"12","key":"poi260035r28","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jama.2022.0992","article-title":"Association of neonatal hypoglycemia with academic performance in mid-childhood.","volume":"327","author":"Shah","year":"2022","journal-title":"JAMA"},{"issue":"8","key":"poi260035r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.12469","article-title":"Application of the reverse fragility index to statistically nonsignificant randomized clinical trial results.","volume":"3","author":"Khan","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1-2","key":"poi260035r30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/0954026021000046128","article-title":"Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample.","volume":"15","author":"Goodman","year":"2003","journal-title":"Int Rev Psychiatry"},{"issue":"6","key":"poi260035r31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218518","article-title":"The validity of the Strengths and Difficulties Questionnaire (SDQ) for children with ADHD symptoms.","volume":"14","author":"Hall","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"poi260035r32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00787-015-0815-0","article-title":"Diagnostic efficiency of the SDQ for parents to identify ADHD in the UK: a ROC analysis.","volume":"25","author":"Algorta","year":"2016","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"poi260035r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.102943","article-title":"Associations between neonatal hypoglycaemia and brain volumes, cortical thickness and white matter microstructure in mid-childhood: an MRI study.","volume":"33","author":"Nivins","year":"2022","journal-title":"Neuroimage Clin"},{"issue":"6","key":"poi260035r34","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41390-022-02410-3","article-title":"Neurodevelopmental correlates of caudate volume in children born at risk of neonatal hypoglycaemia.","volume":"93","author":"Kennedy","year":"2023","journal-title":"Pediatr Res"},{"key":"poi260035r35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpeds.2021.03.057","article-title":"Effect of prophylactic dextrose gel on continuous measures of neonatal glycemia: secondary analysis of the pre-hPOD trial.","volume":"235","author":"Hegarty","year":"2021","journal-title":"J Pediatr"},{"issue":"1","key":"poi260035r36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/anae.16161","article-title":"The winner\u2019s curse: why large effect sizes in discovery trials always get smaller and often disappear completely.","volume":"79","author":"Sidebotham","year":"2024","journal-title":"Anaesthesia"},{"issue":"5","key":"poi260035r37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001863","article-title":"Distinguishing between exploratory and confirmatory preclinical research will improve translation.","volume":"12","author":"Kimmelman","year":"2014","journal-title":"PLoS Biol"},{"issue":"10085","key":"poi260035r38","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(17)31373-9","article-title":"Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial.","volume":"389","author":"Forster","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"poi260035r39","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s12098-024-05138-6","article-title":"Does the 3C (Counselling, Checking and Certification) Initiative prevent hypoglycemia among at-risk stable late preterm and term neonates?\u2014a randomized controlled trial.","volume":"92","author":"Egala","year":"2025","journal-title":"Indian J Pediatr"},{"issue":"1","key":"poi260035r40","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12911-024-02826-3","article-title":"Development and evaluation of a clinical nursing decision support system for the prevention of neonatal hypoglycaemia.","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"poi260035r41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40748-023-00166-0","article-title":"Expressed breast milk and maternal expression of breast milk for the prevention and treatment of neonatal hypoglycemia: a systematic review and meta-analysis.","volume":"9","author":"Oladimeji","year":"2023","journal-title":"Matern Health Neonatol Perinatol"},{"key":"poi260035r42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.earlhumdev.2019.01.010","article-title":"Maternal glycemic control in diabetic pregnancies and neurodevelopmental outcomes in preschool aged children. A prospective cohort study.","volume":"130","author":"Griffith","year":"2019","journal-title":"Early Hum Dev"},{"key":"poi260035r43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2025.114756","article-title":"Gestational diabetes mellitus and school-age cognitive and health outcomes in New Zealand: a matched cohort study.","volume":"287","author":"Alsweiler","year":"2025","journal-title":"J Pediatr"},{"key":"poi260035r27","volume-title":"NZDep2013 Index of Deprivation","author":"Atkinson","year":"2014"},{"key":"poi260035r16","unstructured":"Ministry of Health. HISO 10001:2017 Ethnicity data protocols. Ministry of Health, New Zealand; 2017. https:\/\/www.tewhatuora.govt.nz\/assets\/Our-health-system\/Digital-health\/Health-information-standards\/hiso_10001-2017_ethnicity_data_protocols_21_apr.pdf."}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2850655\/jamapediatrics_harding_2026_oi_260035_1787759716.80335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:01:16Z","timestamp":1788879676000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2850655"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.2486","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}